Compare · GS vs YIN
GS vs YIN
Side-by-side comparison of Goldman Sachs Group Inc. (GS) and Yintech Investment Holdings Limited (YIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GS and YIN operate in Investment Bankers/Brokers/Service (Finance), so they compete in similar markets.
- GS carries a market cap of $115.75B.
- GS has hit the wire 46 times in the past 4 weeks while YIN has been quiet.
- GS has more recent analyst coverage (25 ratings vs 0 for YIN).
- Company
- Goldman Sachs Group Inc.
- Yintech Investment Holdings Limited
- Price
- $927.79-0.38%
- -
- Market cap
- $115.75B
- -
- 1M return
- +10.21%
- -
- 1Y return
- +69.66%
- -
- Industry
- Investment Bankers/Brokers/Service
- Investment Bankers/Brokers/Service
- Exchange
- NYSE
- NASDAQ
- IPO
- 1999
- 2016
- News (4w)
- 46
- 0
- Recent ratings
- 25
- 0
Goldman Sachs Group Inc.
The Goldman Sachs Group, Inc., a financial institution, provides range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through four segments: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management. The company's Investment Banking segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and middle-market lending, relationship lending, and acquisition financing, as well as transaction banking services. This segment also offers underwriting services, such as equity underwriting for common and preferred stock and convertible and exchangeable securities; and debt underwriting for various types of debt instruments, including investment-grade and high-yield debt, bank and bridge loans, and emerging- and growth-market debt, as well as originates structured securities. Its Global Markets segment is involved in client execution activities for cash and derivative instruments; credit and interest rate products; and provision of equity intermediation and equity financing, clearing, settlement, and custody services, as well as mortgages, currencies, commodities, and equities related products. The company's Asset Management segment manages assets across various asset classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, as well as invests in corporate, real estate, and infrastructure entities. Its Consumer & Wealth Management segment offers wealth advisory and banking services, including financial planning, investment management, deposit taking, and lending; private banking; and unsecured loans, as well as accepts saving and time deposits. The company was founded in 1869 and is headquartered in New York, New York.
Latest GS
- SEC Form FWP filed by Goldman Sachs Group Inc.
- CHIEF RISK OFFICER Golten Alex S sold $1,044,782 worth of shares (1,116 units at $936.18), decreasing direct ownership by 30% to 2,578 units (SEC Form 4)
- SEC Form FWP filed by Goldman Sachs Group Inc.
- Amendment: Large owner Goldman Sachs Group Inc bought $5,503 worth of Series A Common Stock (10,006 units at $0.55) and sold $5,082 worth of Series A Common Stock (9,964 units at $0.51) (SEC Form 4)
- SEC Form FWP filed by Goldman Sachs Group Inc.
- SEC Form FWP filed by Goldman Sachs Group Inc.
- SEC Form FWP filed by Goldman Sachs Group Inc.
- SEC Form FWP filed by Goldman Sachs Group Inc.
- SEC Form FWP filed by Goldman Sachs Group Inc.
- SEC Form FWP filed by Goldman Sachs Group Inc.
Latest YIN
- Yintech Announces Completion of Going Private Transaction
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited
- INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - MVC, ARA, YIN, MYOS
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited
- Departure of an Independent Director
- IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - CGIX, YIN, OTEL, BMCH
- Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)
- Lifshitz Law Firm, P.C. Announces Investigation of Pfenex Inc. (NYSE: PFNX), Proteostasis Therapeutics, Inc. (NASDAQ: PTI), Rosetta Stone Inc. (NYSE:RST) and Yintech Investment Holdings Limited (NASDAQ: YIN)
- INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – YIN, BLDR, PTI, CGIX